UK markets closed
NIKKEI 225
38,179.46 -49.64 (-0.13%) HANG SENG
19,115.06 +151.36 (+0.80%) CRUDE OIL
79.17 +0.05 (+0.06%) GOLD FUTURES
2,344.00 +1.00 (+0.04%) DOW
39,431.51 -81.29 (-0.21%) Bitcoin GBP
50,009.98 +1,159.02 (+2.37%)
Aurinia Pharmaceuticals Inc. (AUPH)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 717.96M |
| Enterprise value | 486.58M |
| Trailing P/E | N/A |
| Forward P/E | 55.87 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.77 |
| Price/book (mrq) | 2.00 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.36 |
| 52-week change 3 | -53.86% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 12.43 |
| 52-week low 3 | 4.71 |
| 50-day moving average 3 | 5.14 |
| 200-day moving average 3 | 7.58 |
Share statistics
| Avg vol (3-month) 3 | 2.07M |
| Avg vol (10-day) 3 | 1.46M |
| Shares outstanding 5 | 143.02M |
| Implied shares outstanding 6 | 147.36M |
| Float 8 | 129.8M |
| % held by insiders 1 | 7.53% |
| % held by institutions 1 | 37.86% |
| Shares short (30 Apr 2024) 4 | 10.26M |
| Short ratio (30 Apr 2024) 4 | 7.89 |
| Short % of float (30 Apr 2024) 4 | 7.23% |
| Short % of shares outstanding (30 Apr 2024) 4 | 7.19% |
| Shares short (prior month 28 Mar 2024) 4 | 12.24M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -32.69% |
| Operating margin (ttm) | -13.06% |
Management effectiveness
| Return on assets (ttm) | -8.10% |
| Return on equity (ttm) | -16.69% |
Income statement
| Revenue (ttm) | 191.41M |
| Revenue per share (ttm) | 1.33 |
| Quarterly revenue growth (yoy) | 46.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -47M |
| Net income avi to common (ttm) | -62.56M |
| Diluted EPS (ttm) | -0.43 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 319.37M |
| Total cash per share (mrq) | 2.24 |
| Total debt (mrq) | 88.54M |
| Total debt/equity (mrq) | 24.63% |
| Current ratio (mrq) | 5.61 |
| Book value per share (mrq) | 2.50 |
Cash flow statement
| Operating cash flow (ttm) | -20.39M |
| Levered free cash flow (ttm) | 14.53M |
© 2024 Yahoo. All rights reserved.